Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
Por un escritor de hombre misterioso
Descripción
Microorganisms, Free Full-Text
PDF) CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
The heightened importance of the microbiome in cancer immunotherapy - ScienceDirect
Targeting the gut microbiota for cancer therapy
CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation
Frontiers CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure
Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?
Frontiers Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
The heightened importance of the microbiome in cancer immunotherapy: Trends in Immunology
de
por adulto (el precio varía según el tamaño del grupo)